Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs Revelation Biosciences, Inc. (REVB)

Aptevo Therapeutics Inc. and Revelation Biosciences, Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. is the larger, with a market value of $2.3M against $2.0M — 1.1× the size. Across the 9 metrics below, Revelation Biosciences, Inc. leads on 5 and Aptevo Therapeutics Inc. on 4.

Valuation

Metric APVO REVB Biotechnology median
P/E n/m n/m 10.60
P/S 0.11 n/m 9.40
P/B 0.25 0.20 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.18 0.84 0.66
EV/Sales (0.37) n/m 9.02
Earnings yield (4,659.10%) (2,328.22%) (32.88%)
Free cash flow yield (1,718.19%) (466.23%) (23.13%)

Profitability

Metric APVO REVB Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (446.89%) (276.43%) (51.96%)
Return on assets (186.29%) (214.63%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APVO REVB Biotechnology median
Revenue growth (TTM) 92.94% — 6.76%
EPS growth (last fiscal year) 99.72% 97.72% 29.88%
Revenue growth, 5-year CAGR (26.64%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO REVB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 6.21 4.97
Net debt to EBITDA 0.83 1.18 1.01

Dividend

Metric APVO REVB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APVO REVB Biotechnology median
Market cap 2.30m 2.02m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack